Overview / Abstract: |
Educational Objectives -Discuss the evolution of insulin replacement therapy, including relationships with underlying T2DM disease mechanisms and the latest medication options Target Audience Statement of Need/Program Overview Pharmacist Accreditation Statement Credit Designation Global Contact Information Instructions to Receive Credit System Requirements MAC Fee Information & Refund/Cancellation Policy Disclosure of Conflicts of Interest The faculty reported the following financial relationships or relationships to products or devices they or their spouses/life partners have with commercial interests related to the content of this CME activity: Scott R. Drab, PharmD,CDE,BC-ADM Consultant: Novo Nordisk and sanofi-aventis U.S. LLC Stuart T. Haines, PharmD,BCPS,BCACP, BC-ADM Nothing to disclose Joshua J. Neumiller, CDE, FASCP Consultant: sanofi-aventis U.S. LLC; Grant Research Support: AstraZeneca, Johnson & Johnson, Merck & Co., Inc. and Novo Nordisk; Speakers Bureau: Novo Nordisk The following planners and managers reported the following financial relationships or relationships to products or devices they or their spouses/life partners have with commercial interests related to the content of this CME activity: Amanda Glazar, PhD Nothing to disclose Disclosure of Unlabeled Use The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Disclaimer |
Expiration |
Aug 05, 2017 |
Discipline(s) |
Pharmacy CPE, Physician CME, Physician Assistant CME |
Format |
Webinar / Webcast / Video |
Credits / Hours |
0.10 CEU |
Accreditation |
ACPE |
Presenters / Authors / Faculty |
Scott R. Drab, PharmD, CDE, BC-ADM Stuart T. Haines, PharmD, BCPS, BCACP, BC-ADM Joshua J. Neumiller, PharmD, CDE, FASCP |
Sponsors / Supporters / Grant Providers |
This activity is jointly provided by Global Education Group and Integritas Communications. |
Keywords / Search Terms |
Integritas Communications Integritas Communications type 2 diabetes mellitus Free CE CME Free CE CME |